Literature DB >> 24976611

Sex, age, pubertal development and use of oral contraceptives in relation to serum concentrations of DHEA, DHEAS, 17α-hydroxyprogesterone, Δ4-androstenedione, testosterone and their ratios in children, adolescents and young adults.

Tue Søeborg1, Hanne Frederiksen2, Annette Mouritsen2, Trine Holm Johannsen2, Katharina Maria Main2, Niels Jørgensen2, Jørgen Holm Petersen2, Anna-Maria Andersson2, Anders Juul2.   

Abstract

The influence of sex, age, pubertal development and oral contraceptives on dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), 17α-hydroxyprogesterone (17-OHP), Δ4-androstenedione (Adione), testosterone (T), calculated free testosterone (fT), free androgen index (FAI) and selected ratios in 1798 serum samples from healthy children, adolescents and young adults was evaluated. Samples were analyzed by Turboflow-LC-MS/MS. Sex hormone-binding globulin was analyzed by immunoassay. All steroid metabolite concentrations were positively associated with age and pubertal development in both sexes and generally higher in males than in females except for Adione. The pubertal rise in T in males was more pronounced compared to females, reflecting contribution from the testes. Ratios between steroid metabolites varied and depended on sex and age. All ratios were lower during infancy compared to later in life. Use of oral contraceptives significantly lowered serum concentrations of all steroid metabolites, fT, FAI, the 17-OHP/Adione, the Adione/T and the DHEA/Adione ratios, but not the DHEA/DHEAS ratio. We provide reference ranges for DHEA, DHEAS, 17-OHP, Adione, T, fT, FAI and selected ratios in relation to sex, age and pubertal development. Use of oral contraceptives strongly influences adrenal steroidogenesis and should be considered when diagnosing and monitoring treatment of patients with disorders of sex development.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mass spectrometry; Reference range; Steroid; Tanner stage; Turboflow

Mesh:

Substances:

Year:  2014        PMID: 24976611     DOI: 10.1016/j.cca.2014.06.018

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  20 in total

1.  A rapid and simple liquid chromatography-tandem mass spectrometry method for the measurement of testosterone, androstenedione, and dehydroepiandrosterone in human serum.

Authors:  Wenjuan Xu; Huijun Li; Qing Guan; Ying Shen; Liming Cheng
Journal:  J Clin Lab Anal       Date:  2016-12-02       Impact factor: 2.352

Review 2.  Achievements and Future Directions of the APFCB Mass Spectrometry Harmonisation Project on Serum Testosterone.

Authors:  Ronda F Greaves; Chung S Ho; Kirsten E Hoad; John Joseph; Brett McWhinney; Janice P Gill; Therese Koal; Chris Fouracre; Heidi P Iu; Brian R Cooke; Conchita Boyder; Hai T Pham; Lisa M Jolly
Journal:  Clin Biochem Rev       Date:  2016-05

3.  Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.

Authors:  A Nordenström; S F Ahmed; E van den Akker; J Blair; M Bonomi; C Brachet; L H A Broersen; H L Claahsen-van der Grinten; A B Dessens; A Gawlik; C H Gravholt; A Juul; C Krausz; T Raivio; A Smyth; P Touraine; D Vitali; O M Dekkers
Journal:  Eur J Endocrinol       Date:  2022-04-21       Impact factor: 6.558

4.  Age-dependent Increases in Adrenal Cytochrome b5 and Serum 5-Androstenediol-3-sulfate.

Authors:  Juilee Rege; Shigehiro Karashima; Antonio M Lerario; Joshua M Smith; Richard J Auchus; Josephine Z Kasa-Vubu; Hironobu Sasano; Yasuhiro Nakamura; Perrin C White; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2016-09-13       Impact factor: 5.958

Review 5.  Sex is a defining feature of neuroimaging phenotypes in major brain disorders.

Authors:  Lauren E Salminen; Meral A Tubi; Joanna Bright; Sophia I Thomopoulos; Alyssa Wieand; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2021-05-05       Impact factor: 5.038

6.  A Researcher's Guide to the Measurement and Modeling of Puberty in the ABCD Study® at Baseline.

Authors:  Theresa W Cheng; Lucía Magis-Weinberg; Victoria Guazzelli Williamson; Cecile D Ladouceur; Sarah L Whittle; Megan M Herting; Kristina A Uban; Michelle L Byrne; Marjolein E A Barendse; Elizabeth A Shirtcliff; Jennifer H Pfeifer
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-05       Impact factor: 6.055

7.  Reference Curves for Pediatric Endocrinology: Leveraging Biomarker Z-Scores for Clinical Classifications.

Authors:  Andre Madsen; Bjørg Almås; Ingvild S Bruserud; Ninnie Helen Bakken Oehme; Christopher Sivert Nielsen; Mathieu Roelants; Thomas Hundhausen; Marie Lindhardt Ljubicic; Robert Bjerknes; Gunnar Mellgren; Jørn V Sagen; Pétur B Juliusson; Kristin Viste
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

8.  Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status.

Authors:  Graeme Eisenhofer; Mirko Peitzsch; Denise Kaden; Katharina Langton; Christina Pamporaki; Jimmy Masjkur; George Tsatsaronis; Anastasios Mangelis; Tracy A Williams; Martin Reincke; Jacques W M Lenders; Stefan R Bornstein
Journal:  Clin Chim Acta       Date:  2017-05-04       Impact factor: 3.786

Review 9.  Steroid hormone analysis in diagnosis and treatment of DSD: position paper of EU COST Action BM 1303 'DSDnet'.

Authors:  A Kulle; N Krone; P M Holterhus; G Schuler; R F Greaves; A Juul; Y B de Rijke; M F Hartmann; A Saba; O Hiort; S A Wudy
Journal:  Eur J Endocrinol       Date:  2017-02-10       Impact factor: 6.664

10.  Liquid Chromatography-Tandem Mass Spectrometry-Based Characterization of Steroid Hormone Profiles in Healthy 6 to 14-Year-Old Male Children.

Authors:  Bing-Yan Cao; Chun-Xiu Gong; Di Wu; Xue-Jun Liang; Wen-Jing Li; Min Liu; Chang Su; Miao Qin; Xi Meng; Jia-Jia Chen; Li-Ya Wei
Journal:  Chin Med J (Engl)       Date:  2018-04-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.